[1]
E. AVŞAR, “A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazolebased triple therapy for the eradication of Helicobacter pylori in dyspeptic patients”, Turkish Journal of Gastroenterology, vol. 24, no. 4, pp. 316–321, Jan. 2013.